EDT Vor Bio (VOR) files $350M mixed securities shelfLight Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second ...
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment Sys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results